Neuro-Oncology Reviews

Volume 22 Number 5
15 March 2020

Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 5, 15 March

Hani U, Bakhshi SK, Shamim MS.
Primary Intracranial Malignant Melanoma.
J Pak Med Assoc. 2020 Mar;70(3):554-556→. PMID: 32207448→. Review. ˍ

Sekimata K, Sato T, Sakai N.
ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma.
Chem Pharm Bull (Tokyo). 2020 Mar 1;68(3):194-200→. doi: 10.1248/cpb.c19-00882→. PMID: 32115526→. Review. ˍ

von Bueren AO, Hagel C, Rutkowski S.
Cerebrospinal fluid evaluation in adult patients with medulloblastoma.
Lancet Oncol. 2020 Mar 1;21(3):e12032135104→. doi: 10.1016/S1470-2045(20)30070-X32135104→. PMID: 32135104→. Comment. ˍ
Refers to: Franceschi E, et al., EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. Lancet Oncol. 2019 Dec 1;20(12):e715-e728→. doi: 10.1016/S1470-2045(19)30669-2→. PMID: 31797797→. Guidelines. ˍ

Jakola AS, Sagberg LM, Gulati S, Solheim O.
Advancements in predicting outcomes in patients with glioma: a surgical perspective.
Expert Rev Anticancer Ther. 2020 Mar 2;20(3):167-177→. doi: 10.1080/14737140.2020.1735367→. PMID: 32114857→. Review. ˍ

Szychot E, Goodden J, Whitfield G, Curry S.
Children's Cancer and Leukaemia Group (CCLG): review and guidelines for the management of meningioma in children, teenagers and young adults.
Br J Neurosurg. 2020 Mar 2;34(2):142-153→. doi: 10.1080/02688697.2020.1726286→. PMID: 32116043→. Review, Guidelines. ˍ

*

Moretti E, Favero G, Rodella LF, Rezzani R.
Melatonin's Antineoplastic Potential Against Glioblastoma.
Cells. 2020 Mar 3;9(3):E599→. doi: 10.3390/cells9030599→. PMID: 32138190→. Review. ˍ

Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ, Kim KW.
Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials.
Korean J Radiol.2020 Mar 3;21(4):471-482→. doi: 10.3348/kjr.2019.0839→. PMID: 32193895→. Review, Meta-analysis. ˍ

Adile AA, Kameda-Smith MM, Bakhshinyan D, Banfield L, Salim SK, Farrokhyar F, Fleming AJ.
Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
Syst Rev. 2020 Mar 4;9(1):47→. doi: 10.1186/s13643-020-01307-8→. PMID: 32127049→. Review. ˍ

Brahm CG, van Linde ME, Enting RH, Schuur M, Otten RHJ, Heymans MW, Verheul HMW, Walenkamp AME.
The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review.
Cancers (Basel). 2020 Mar 4;12(3):E586→. doi: 10.3390/cancers12030586→. PMID: 32143288→. Review. ˍ

Luís Â, Marcelino H, Rosa C, Domingues F, Pereira L, Cascalheira JF.
The effects of cannabinoids on glioblastoma growth: A systematic review with meta-analysis of animal model studies.
Eur J Pharmacol. 2020 Mar 4;876:173055→. doi: 10.1016/j.ejphar.2020.173055→. PMID: 32145324→. Review, Meta-analysis. ˍ

Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Mar 5→. NCBI Bookshelf ID: NBK65913→. PMID: 26389351→. Review. ˍ

Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Feb 6→. NCBI Bookshelf ID: NBK65981→. PMID: 26389418→. Review. ˍ

Parikh BB, Neil EC.
Evolving Strategies to Potentially Further Optimize Surgical Interventions in Brain Cancer.
Curr Oncol Rep. 2020 Mar 6;22(4):32→. doi: 10.1007/s11912-020-0896-x→. PMID: 32140793→. Review. ˍ

Ritchey AK, et al., PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Mar 6→. NCBI Bookshelf ID: NBK65903→. PMID: 26389341→. Review. ˍ

Wong A et al., Ontario Health (Quality).
5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2020 Mar 6; 20(9):1-92→. PMID: 32194883→. Review. ˍ

Macchi ZA, Kleinschmidt-DeMasters BK, Orjuela KD, Pastula DM, Piquet AL, Baca CB.
Glioblastoma as an autoimmune limbic encephalitis mimic: A case and review of the literature.
J Neuroimmunol. 2020 Mar 7;342:577214→. doi: 10.1016/j.jneuroim.2020.577214→. PMID: 32182452→. Case report, Review. ˍ

Ahir BK, Engelhard HH, Lakka SS.
Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma.
Mol Neurobiol. 2020 Mar 9→. doi: 10.1007/s12035-020-01892-8→. PMID: 32152825→. Review. ˍ

Marenco-Hillembrand L, Wijesekera O, Suarez-Meade P, Mampre D, Jackson C, Peterson J, Trifiletti D, Hammack J, Ortiz K, Lesser E, Spiegel M, Prevatt C, Hawayek M, Quinones-Hinojosa A, Chaichana KL.
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis.
J Neurooncol. 2020 Mar 9;147(2):297-307→. doi: 10.1007/s11060-020-03451-6→. PMID: 32157552→. Review. ˍ

Montoya ML, Kasahara N, Okada H.
Introduction to immunotherapy for brain tumor patients: challenges and future perspectives.
Neurooncol Pract. 2020 Mar 9;7(5):465-476→. doi: 10.1093/nop/npaa007→. PMID: 33014387→. Review. ˍ

Pareja-Peña F, Burgos-Molina AM, Sendra-Portero F, Ruiz-Gómez MJ.
Evidences of the (400 MHz - 3 GHz) radiofrequency electromagnetic field influence on brain tumor induction.
Int J Environ Health Res. 2020 Mar 9, 2022;32(1):121-130→. doi: 10.1080/09603123.2020.1738352→. PMID: 32149530→. Review. ˍ

Wang Y, Zhao B, Chen W, Liu L, Chen W, Zhou L, Kong Z, Dai C, Wang Y, Ma W.
Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications.
Aging Dis. 2020 Mar 9;11(2):448‐461→. doi: 10.14336/AD.2019.0527→. PMID: 32257553→. Review. ˍ

Zou H, Poore B, Broniscer A, Pollack IF, Hu B.
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.
Cancers (Basel). 2020 Mar 10;12(3):E643→. doi: 10.3390/cancers12030643→. PMID: 32164294→. Review. ˍ

Muggia FM et al, PDQ Adult Treatment Editorial Board.
Adult Central Nervous System Tumors Treatment (PDQ®): Patient Version.
PDQ Cancer Inf Summ. 2020 Mar 11→. NCBI Bookshelf ID: NBK66023→. PMID: 26389458→. Review. ˍ

Buruiană A, Florian ȘI, Florian AI, Timiș TL, Mihu CM, Miclăuș M, Oșan S, Hrapșa I, Cataniciu RC, Farcaș M, Șușman S.
The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations.
Int J Mol Sci. 2020 Mar 12;21(6):E1950→. doi: 10.3390/ijms21061950→. PMID: 32178454→. Review. ˍ

Delgado-Martín B, Medina MÁ.
Advances in the Knowledge of the Molecular Biology of Glioblastoma and Its Impact in Patient Diagnosis, Stratification, and Treatment.
Adv Sci (Weinh). 2020 Mar 12;7(9):1902971→. doi: 10.1002/advs.201902971→. PMID: 32382477→. Review. ˍ

Ryall S, Tabori U, Hawkins C.
Pediatric low-grade glioma in the era of molecular diagnostics.
Acta Neuropathol Commun. 2020 Mar 12;8(1):30→. doi: 10.1186/s40478-020-00902-z→. PMID: 32164789→. Review. ˍ

Vollmann-Zwerenz A, Leidgens V, Feliciello G, Klein CA, Hau P.
Tumor Cell Invasion in Glioblastoma.
Int J Mol Sci. 2020 Mar 12;21(6):E1932→. doi: 10.3390/ijms21061932→. PMID: 32178267→. Review. ˍ

Zhang H, Zhou Y, Cui B, Liu Z, Shen H.
Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma.
Biomed Pharmacother. 2020 Mar 12;126:110086→. doi: 10.1016/j.biopha.2020.110086→. PMID: 32172060→. Review. ˍ

Tewarie IA, Senders JT, Hulsbergen AFC, Kremer S, Broekman MLD.
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results.
Neurosurg Rev. 2020 Mar 14→. doi: 10.1007/s10143-020-01277-4→. PMID: 32172480→. Review. ˍ